Background and purpose:
Cancer cachexia is one of the most common causes of death among cancer
patients, no effective anti-cachectic treatment is currently available.
In experimental cachectic animal models, aberrant activation of STAT3 in
skeletal muscle has been found to contribute to muscle wasting. However,
its clinical association, the factors regulating STAT3 activation, and
the molecular mechanisms remain incompletely understood.